Medtronic Exec Talks About Neuro Panel Recommendations

Medtronic's Stacey Pugh talked to Medtech Insight after FDA's Neurological Devices Advisory Panel met to talk about how intracranial aneurysm devices should be evalauted in clinical trials. While she didn't find anything surprising about the panel's recommendations, she says it gives industry more clarity and consistency about the direction they need to take.